Colorectal Cancer — Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer
Citation(s)
Phase III, Randomized, Double Blind, Placebo Controlled Study of Rofecoxib in Colorectal Cancer Patients Following Adjuvant Chemotherapy